Reproductive period and risk of dementia in postmenopausal women

JAMA

Volumn 285, Issue 11, 2001, Pages 1475-1481

  Geerlings, Mirjam I ^a   Ruitenberg, Annemieke ^a   Witteman, Jacqueline C M ^a   Van Swieten, John C ^a   Hofman, Albert ^a   Van Duijn, Cornelia M ^a   Breteler, Monique M B ^a   Launer, Lenore J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ESTROGEN;

ADULT; AGE; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; DEMENTIA; ESTROGEN THERAPY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; OUTCOMES RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0035925777     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.11.1475     Document Type: Article

References (49)

1. Estrogens, bone loss and preservation
2. Age at natural menopause and risk of cardiovascular disease
3. Menopausal status and risk factors for cardiovascular disease
4. Estrogen and basal forebrain cholinergic neurons: Implications for brain aging and Alzheimer's disease-related cognitive decline
5. Estrogen actions in the central nervous system
6. Menopause and estrogen deficiency as a risk factor in dementing illness: Hypothesis on the biological basis
7. Use of estrogens for the prevention and treatment of Alzheimer's disease
8. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia?
9. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
10. Cardiovascular disease and distribution of cognitive function in elderly people: The Rotterdam Study
11. Estrogen deficiency and risk of Alzheimer's disease in women
12. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
13. Estrogen replacement therapy and risk of Alzheimer disease
14. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging
15. Estrogen replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging
16. Postmenopausal estrogen replacement therapy and risk of AD: A population-based study
17. The epidemiology of estrogen replacement therapy and Alzheimer's disease
18. The effect of estrogen replacement therapy on cognitive function in women: A critical review of the literature
19. HRT and dementia
20. Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women
21. Cognitive function and endogenous sex hormones in older women
22. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations
23. Determinants of disease and disability in the elderly: The Rotterdam Elderly Study
24. Prevalence of Alzheimer's disease and vascular dementia: Association with education
25. Incidence and risk of dementia
26. "Minimental state": A practical method for grading the cognitive state of patients for the clinician
27. A semistructured clinical interview for the assessment of diagnosis and mental state in the elderly: The Geriatric Mental State Schedule, I: Development and reliability
28. CAMDEX: A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia
29. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
30. Dietary assessment in the elderly: Validation of a semiquantitative food frequency questionnaire
31. Estrogen use and early onset Alzheimer's disease: A population-based study
32. Is early natural menopause a biologic marker of health and aging?
33. Age at natural menopause and mortality
34. Age at natural menopause and total mortality and mortality from ischemic heart disease: The Adventist Health Study
35. Cognitive function in nondemented older women who took estrogen after menopause
36. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women
37. Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women
38. Estrogen use and verbal memory in healthy postmenopausal women
39. Estrogen replacement therapy and cognitive function in older women
40. Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study
41. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial
42. Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial
43. Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: The Cardiovascular Health Study
44. Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen
45. Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4
46. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: A possible clue to the higher incidence of Alzheimer disease in women
47. Estrogen use, APOE, and cognitive decline: Evidence of gene-environment interaction